Scientific discoveries for the benefit of patients

Translational medicine aims to facilitate new therapies and medical procedures by implementing research findings in patient care, and by applying clinical data in research. This requires understanding of both science and medicine. In Master's Programme in Translational medicine (TRANSMED) this is promoted throughout the curriculum, which is based on interactive, student-centered educational approaches. The students also have ample opportunities for direct interactions with both researchers and clinicians to to adopt and practice interdisciplinary communication skills.

News

@TRANSMEDUniHel

We are introducing the @helsinkiuni Faculty of Medicine's research groups' pages here on Twitter every week! This t… twitter.com/i/web/status/1…

Congratulations @helsinkiuni Professor Satu Mustjoki for the ERC Proof of Concept Grant! Mustjoki’s research group… twitter.com/i/web/status/1…

The first common genetic risk variants for autism have been identified helsinki.fi/en/news/health… @amchelsinki

From Harvard to Finland: FIMM director Mark Daly (@dalygene) wants to turn Helsinki into the CERN of genetic resear… twitter.com/i/web/status/1…

How to Apply

The application period for the International Master's Programmes starting in autumn 2019 closed on Jan 11, 2019. The next application period will start towards the end of 2019. To keep updated about the application dates, sign up for our Admissions Newsletter.

Study in Helsinki

Helsinki is one of the most liveable cities in Europe. It is compact, safe and surrounded by nature. Everything simply works. At the University of Helsinki, you study at the oldest and largest university in Finland. As one of the world’s top 1% multidisciplinary research universities, we believe that science can change attitudes, people and society – for the world.

Networking

TRANSMED is hosted by the Faculty of Medicine, but also other units of the Academic Medical Center Helsinki and the Helsinki Institute of Life Sciences (HiLIFE) such as the Helsinki University Central Hospital, Institute of Molecular Medicine Finland and the Neuroscience Center actively participate in the programme.